113 related articles for article (PubMed ID: 35305145)
21. Androgen Receptor Immunohistochemical Expression in Undifferentiated/Dedifferentiated Endometrial Carcinoma.
Cao J; Hacking S; Chavarria-Bernal HD; Bhuiya TA; Khutti S
Int J Gynecol Pathol; 2022 Jan; 41(1):28-34. PubMed ID: 33399351
[TBL] [Abstract][Full Text] [Related]
22. ZEB1 expression is frequently detected in undifferentiated and de-differentiated carcinomas, but is not specific among endometrial carcinomas.
Kihara A; Amano Y; Fukushima N; Fujiwara H; Niki T
Histopathology; 2022 Jul; 81(1):108-118. PubMed ID: 35478361
[TBL] [Abstract][Full Text] [Related]
23. Stromal p16 Expression Helps Distinguish Atypical Polypoid Adenomyoma From Myoinvasive Endometrioid Carcinoma of the Uterus.
Kihara A; Amano Y; Yoshimoto T; Matsubara D; Fukushima N; Fujiwara H; Niki T
Am J Surg Pathol; 2019 Nov; 43(11):1526-1535. PubMed ID: 31600177
[TBL] [Abstract][Full Text] [Related]
24. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
Lim D; Murali R; Murray MP; Veras E; Park KJ; Soslow RA
Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621
[TBL] [Abstract][Full Text] [Related]
25. Undifferentiated endometrial carcinoma arising in the background of high-grade endometrial carcinoma - Expanding the definition of dedifferentiated endometrial carcinoma.
Busca A; Parra-Herran C; Nofech-Mozes S; Djordjevic B; Ismiil N; Cesari M; Nucci MR; Mirkovic J
Histopathology; 2020 Nov; 77(5):769-780. PubMed ID: 32557836
[TBL] [Abstract][Full Text] [Related]
26. [Endometrial carcinomas and precursor lesions--new aspects].
Schmidt D
Pathologe; 2009 Jul; 30(4):261-7. PubMed ID: 19495762
[TBL] [Abstract][Full Text] [Related]
27. Mixed and Ambiguous Endometrial Carcinomas: A Heterogenous Group of Tumors With Different Clinicopathologic and Molecular Genetic Features.
Espinosa I; D'Angelo E; Palacios J; Prat J
Am J Surg Pathol; 2016 Jul; 40(7):972-81. PubMed ID: 26975040
[TBL] [Abstract][Full Text] [Related]
28. Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1/INI1-deficient tumours.
Hoang LN; Lee YS; Karnezis AN; Tessier-Cloutier B; Almandani N; Coatham M; Gilks CB; Soslow RA; Stewart CJ; Köbel M; Lee CH
Histopathology; 2016 Oct; 69(4):560-9. PubMed ID: 27101785
[TBL] [Abstract][Full Text] [Related]
29. BRG1, INI1, and ARID1B Deficiency in Endometrial Carcinoma: A Clinicopathologic and Immunohistochemical Analysis of a Large Series From a Single Institution.
Kihara A; Amano Y; Matsubara D; Fukushima N; Fujiwara H; Niki T
Am J Surg Pathol; 2020 Dec; 44(12):1712-1724. PubMed ID: 32910019
[TBL] [Abstract][Full Text] [Related]
30. Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms.
Murray SK; Clement PB; Young RH
Am J Surg Pathol; 2005 Feb; 29(2):157-66. PubMed ID: 15644772
[TBL] [Abstract][Full Text] [Related]
31. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
32. Serous versus high-grade endometrioid endometrial carcinoma: immunohistochemistry of RFP is not useful for differentiation.
Ussakli C; Usubutun A; Dincer N; Dolgun A; Bülbül D; Isikdogan Z; Haberal N; Ozen O; Tezel GG
Pol J Pathol; 2016; 67(3):221-227. PubMed ID: 28155970
[TBL] [Abstract][Full Text] [Related]
33. A report of two cases of dedifferentiated endometrioid carcinoma: A newly described underrecognized tumor of poor prognosis.
Boler AK; Akhtar S; Bandyopadhyay A; Roy S
Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S91-S93. PubMed ID: 32108637
[TBL] [Abstract][Full Text] [Related]
34. Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases.
Darvishian F; Hummer AJ; Thaler HT; Bhargava R; Linkov I; Asher M; Soslow RA
Am J Surg Pathol; 2004 Dec; 28(12):1568-78. PubMed ID: 15577675
[TBL] [Abstract][Full Text] [Related]
35. Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.
Bartosch C; Manuel Lopes J; Oliva E
Adv Anat Pathol; 2011 Nov; 18(6):415-37. PubMed ID: 21993268
[TBL] [Abstract][Full Text] [Related]
36. Corded and hyalinized endometrioid carcinoma: Summary of clinical, histological, immunohistochemical and molecular data.
Travaglino A; Arciuolo D; Santoro A; Raffone A; Raimondo D; Casadio P; Seracchioli R; Fulgione C; Guida M; Mollo A; Inzani F; Zannoni GF
Pathol Res Pract; 2023 Jul; 247():154515. PubMed ID: 37209572
[TBL] [Abstract][Full Text] [Related]
37. Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
Hoang LN; McConechy MK; Köbel M; Han G; Rouzbahman M; Davidson B; Irving J; Ali RH; Leung S; McAlpine JN; Oliva E; Nucci MR; Soslow RA; Huntsman DG; Gilks CB; Lee CH
Am J Surg Pathol; 2013 Sep; 37(9):1421-32. PubMed ID: 24076778
[TBL] [Abstract][Full Text] [Related]
38. Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?
Silva EG; Deavers MT; Bodurka DC; Malpica A
Int J Gynecol Pathol; 2006 Jan; 25(1):52-8. PubMed ID: 16306785
[TBL] [Abstract][Full Text] [Related]
39. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma.
Russo M; Broach J; Sheldon K; Houser KR; Liu DJ; Kesterson J; Phaeton R; Hossler C; Hempel N; Baker M; Newell JM; Zaino R; Warrick JI
Hum Pathol; 2017 Sep; 67():69-77. PubMed ID: 28712776
[TBL] [Abstract][Full Text] [Related]
40. Role of Immunohistochemistry to Distinguish Grade 3 Endometrioid Carcinoma and Uterine Serous Carcinoma.
Zaidi A; Gupta P; Gupta N; Rajwanshi A; Rai B; Gainder S
Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):42-48. PubMed ID: 31815745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]